Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What are your reasons for buying? Just curious. I still own shares of this when it was DIGITAL DESCRIPTOR back in 2012 or there about.
I FOUND THE INFORMATION I NEEDED THANKS AGAIN. REASON I DON'T TRUST THIS SYMBOL IT HAS HAD A LONG HISTORY, AS I HAVE BEEN IN IT BEFORE TIME BEGAN. I NEVER BUY ON MARGIN THEREFORE I HOLD ONTO THINGS PAST THEIR EXPIRATION DATE, AND I STILL HAVE SHARES FROM LONG AGO... I WILL KEEP AN EYE OUT TO SEE IF THIS DOES GO ANYWHERE...
WHEN ARE THEY GOING TO GO PINK ON OTC AND HAVE THE STOP SIGNED REMOVED?
THANKS...
I had 20 otc stocks up today...watching...all 20 were down in the morning and only 2 finished green...it was not good day all round...
Sounds good....
CJ do you know if they are going to get the STOP sign removed anytime soon?
Thanks
Well....It maybe for you or maybe not...regardless I have made over $200,000 dollars on this aborted baby...Still have shares that I am holding for later...If you do not like it here just move on to your HAPPY PLACE.....
GLTA $HBRM$
Thanks
Did find a few comments on Yahoo Finance but don't know if it is verified.
Somebody's buying?
Yes. I am too. I may sell a small share to get out of some of this and hold the rest.
Thanks
Do you any reason for the volume to pick up on this stock? I have held it for a long time and I have not seen any current or new info on it.
Where was this stock last year?????NO BID
What has changed with the company since then?????
Is HBRM making money now where is it selling its products, in how many countries...
If you are not interested in this stock or feel it will not move, then move on to one you like...I think it is better to go up slowly and hold then to just have it jump to the sky and fall right down...
If it goes low enough I will buy more...
That would be great...I am trying to remember back in 2012 they may have been on NASDAQ
I agree. I guess my point was that HBRM back in 2012 did not have as much potential as they have now. That being said this is the era of COVID19 and certain sectors in the market are rising just because of that.
Yesterday my MNJA jumped with the possibility that they will take MJ out of schedule one, maybe legalize it? There maybe room for the good Doctor to have several products associated with MJ. I know about the terpins but maybe she could come up with others...
Off topic...a little...I have shares I bought in 2012 for $3.60...Is it possible to go back up to that price? I remember when this was a $4.00 stock...
Thanks for the info
E*trade has market caster which is free but no level 2.
Thanks
I use E*trade for buying and selling but they don’t have Level 2 for otc stocks. Who is the best to pay for level 2 quotes. I am not able to see what MM are active and how deep the book is.
Thanks
GO HBRM$$$
I am here watching and waiting.....I bought this back in 2013/14...I was really underwater so I bought a lot at .0001. Held on and am glad I did... I sold some to get my money back for the cost...Rest will ride into the future.....Hopefully a profitable one....I think if this starts moving past .003 the flippers will come back and the chatter on the boards will pick up...
GLTA...
GO HBRM$$$$$
Thanks
GO HBRM$$$
I think that is the mindset of those who trade in penny stocks. They look at what's hot for the moment and then jump in then out for a gain. They are traders not investors.
OK Thanks
up grade? meant up-list
Can you please provide a link where the Doc says she wants to upgrade.
Thanks
GO HBRM$$$$
I thought they were into inkless fingerprints for criminal justice applications..Bought this years ago and has been dead ever since. What about the STOP sign on the OTC site...
Correction Post #72900
Your welcome...
HBRM$$$
POST# 72899 MENTIONS IT
You sent me a private message the other day saying that I posted on wrong board. The reason I posted that information was because someone ask about that company and where they could get information about it. This is the company that HBRM may merge with. I wanted to give some info on it so the other poster could see. The company is listed on the Canadian market not US and they could not find it....
Use of Funds
With the ~$4.5 million raised after fees and including prior working capital of ~$500,000, the company aims to allocate as such
USE OF FUNDS AMOUNT
R&D (TRP – 8802) $1,500,000
R&D (TRP – 1101) $400,000
General and Admin Expenses $2,200,000
Unallocated Working Capital $400,000
Market Opportunity
Tryp aims to seek out licensing, acquisition, and co-development opportunities for its drug candidates during and around a Phase 2 stage of development.
Phase 3 trials are extensive and costly, therefore Tryp management is open to any and all potential monetization strategies including acquisition.
The company currently has no revenue and will continue to incur losses for the foreseeable future. This is expected for an early stage pharmaceutical company, but investors should be aware that much is riding on the success of Tryp’s two potential drugs (TRP-1001 and TRP-8802). Brain and Nervous system drugs are also notorious for the difficulty of success.
The company also specifically calls out Compass Pathways in its prospectus as potential competition.
That said, success of one or both drug candidates would represent a massive market opportunity.
Drugs targeting chronic pain conditions (such as Tryp’s TRP-8802) including fibromyalgia represent a multi-billion dollar opportunity. Before facing generic competition, Eli Lilly’s Cymbalta and Pfizer’s Lyrica achieved ~$5 billion in annual sales respectively.
Oncology on the other hand (what TRP-1001 is working on) represents a $100 billion+ opportunity. Oncology is also one of the most active M&A areas of the market. In 2019 alone, BMS acquired Celgene for $74 billion and Astra Zeneca did a deal with Daiichi Sankyo for a combined valuation of $6.9 billion. We don’t expect that M&A activity in this corner of the market will slow down anytime soon.
A Note to Potential Investors
Investors seeking information on Tryp Therapeutics should ensure they are looking at data for the correct company: Tryp Technologies is a pre-IPO ride-sharing company.
Tryp was formerly known as Actos Pharma. But the name was changed on June 30, 2020.
Today you can buy shares of Tryp under the ticker symbol TRYP, which alludes to the body’s 5-hydrotrypamine receptors, through which the body metabolizes psilocybin.
Reader Interactions
Leave a Reply
Your email address will not be published. Required fields are marked *
Comment
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.
Primary Sidebar
Search the site ...
Search the site ...
The Next Wave
of BioTech
Subscribe to our newsletter to get the latest business and investing news about the burgeoning psychedelics industry.
Email
JOIN OUR COMMUNITY
RECENT POSTS
MindMed Expands Psychedelic Microdosing Division, Adds Groundbreaking Study Evaluating LSD Microdosing Through Next-Gen Digital Clinical Markers January 12, 2021
Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics January 11, 2021
Fluence: Training the Next Generation of Psychedelic Treatment Professionals January 8, 2021
COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care January 8, 2021
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand January 7, 2021
Psychedelics by TradingView
INTERVIEW SERIES
fluence psychedelic therapy
CaaMTech Davis Wuolle
Tryp’s Active Drug Candidates
Tryp Therapeutics currently has two active development programs:
TRP-8802
Tryp has also launched a Psilocybin for Neuropsychiatry (PFN) program, which focuses on the use of synthetic psilocybin to treat multiple disorders. TRP-8802 is currently the lead candidate in the program.
The PFN program will focus on developing orally-delivered drugs that focus on neuropsychiatric disorders such as fibromyalgia, a Chronic and debilitating disorder characterized by pain, fatigue, and depression.
There are currently three drugs with FDA approval that treat fibromyalgia: Pregabalin (Lyrica), Duloxetine (Cymbalta) and Milnacipran (Savella). Eli Lilly’s Lyrica and Pfizer’s Cymbalta each have sales of over $1 billion a year.
Although the current drugs are useful, none of them cover the full burden of the disease, and only half of patients receive complete relief. The drugs are also fraught with side-effects and are only useful for a handful of symptoms. Due to this, more than 30% of fibromyalgia patients turn to opiods.
Tryp believes they can change this with the use of psilocybin and TRP-8802.
To a lesser extent, the company is also evaluating additional applications with PFN including Prader-Willi Syndrome (PWS) and other neuropsychiatric-based chronic pain conditions and eating disorders.
TRP-1001
Tryp is studying TRP-1001, also known as razoxane, as a potential treatment for Soft Tissue Sarcoma (STS). STS currently accounts for around 1% of all cancers in adults and 7% in children. The National Cancer Institute estimated that in 2017 there were ~150,000 people in the US living with STS, leading Tryp to believe TRP-1001 will qualify for Orphan Drug Status.
Tryp believes that because there is a large amount of existing clinical data regarding
Razoxane, it may allow Tryp to move on to Phase 2 trials for TRP-1001, skipping preclinical or Phase 1 trials. For investors, this means the company would be able to save a significant amount of time and money for bringing the drug to market.
Investors should note that TRP-1001 is a non-psychedelic drug candidate.
So sorry to hear...Hope he get better soon...
You know I have tried to stay away from all this jibber jabber about who did what and who said what politically ...If this turns into CNN MSNBC FOX I will just tune it out. I wanted to be on this board because of the conversation about HBRM. I don't see what happened yesterday with a penny stock falling because of that. It started down and stop limit orders were triggered and then some panicked and sold... This time we are living in is very polarizing....Two things one should not bring to the board Politics and Religion... I am not here for arguing about this, so that all I have to say...
I second the motion....passed....